Therefore, we proved independent CRC patient cohorts to determine whether high MACC1 expression was associated with genomic alteration events occurring in CRC tumors, whether they could predict metastasis formation in early-stage patients. The gene discussed is MACC1; the disease is colorectal carcinoma.